Dr. Robert Kormos is currently a professor with tenure specializing in cardiothoracic surgery at the University of Pittsburgh. He is the director of UPMC's Artificial Heart Program and co-director of the Heart Transplantation Program. Dr. Kormos has been on the faculty at the University of Pittsburgh since 1987 after completion of fellowships in research and transplant surgery. He is also a staff cardiothoracic surgeon at several UPMC hospitals and Pittsburgh’s Veterans Administration Hospital.
While at the University of Pittsburgh, his research and clinical interests have been focused on mechanical circulatory support, resulting in his authorship/co-authorship of over 280 published articles, over 300 proceedings papers, 40 book chapters, and a textbook on the subject. He has made over 355 regional, national, and international invited lectures. He is an associate editor for The Journal of Heart and Lung Transplantation, is on the editorial board of the Journal of Cardiac Surgery, a member of more than 18 professional societies, and is internationally regarded for his clinical and research work in organ transplantation and in the use of cardiac assist devices as temporary or permanent support for patients with end-stage heart disease.
Throughout his career, Dr. Kormos has provided much professional and scientific service. A few examples follow: He is the chair, Society for Thoracic Surgery (STS) Workforce on Clinical Education, and a member of the STS/AATS Workforce on New Technology and the STS/AATS Workforce on Adult Cardiac and Vascular Surgery. Dr. Kormos also serves as a member of the UPMC Data Governance Council and the Executive Board of Directors of the American Board of Stem Cell Medicine and Surgery. He is also a Fellow, American Heart Association, Council on Cardio-Thoracic and Vascular Surgery. He is also a member of the Joint Task force on education of the American College of Cardiology and the STS.
Dr. Kormos is the co-principal investigator for The Randomized Evaluation of VAD InterVEntion Before Inotropic Therapy (REVIVE-IT) trial. This multi-million dollar effort explores the potential benefits of earlier implantation of left ventricular assist devices (LVADs) in nontransplant candidates with less advanced heart failure (HF) at NYHAC IIIb. He is also the co-principal investigator on the NHLBI contract entitled, “Interagency Registry of Mechanical Circulatory Support for End Stage Heart Failure.” His research interests additionally include:
- Telemedicine Project for heart failure and ventricular-assist devices for home monitoring of indicators of cardiovascular health.
- Work towards increasing the population of patients tested for myocardial recovery to give insight into mechanisms in patients chronically supported with LVADs.
- Developed a Biosensor Consortium with University of Pittsburgh and Carnegie Mellon University.
- Serve as the National Principal Investigator for the new Minimally Invasive LVAD by the Heartware Corporation which will see first in-man implants in Europe.
Dr. Kormos is the recipient of multiple awards including the President's Award at the 7th Annual Scientific Session of the International Society for Heart and Lung Transplantation in 1987. He was also elected to serve as president of the International Society for Heart and Lung Transplantation from 1999-2000. As a further honor, Dr. Kormos has been listed for the past 10 years in the America's Top Doctors published by Castle Connolly Medical, Ltd. In 2006, he received the Carnegie Science Center Awards for Excellence, Chairman’s Award. US News and World Report named him a “doctor in the top 1% in the nation in his specialty” in 2012.
View a list of Dr. Kormos’ publications here.
Dr. Robert L. Kormos
Phone: (412) 648-6259